Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000793158 | SCV000932499 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2023-02-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala1362Glyfs*4) in the CC2D2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CC2D2A are known to be pathogenic (PMID: 19777577). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with CC2D2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 640187). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005036132 | SCV005664585 | likely pathogenic | Meckel syndrome, type 6; Joubert syndrome 9; COACH syndrome 2; Retinitis pigmentosa 93 | 2024-05-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004723184 | SCV005335510 | likely pathogenic | CC2D2A-related disorder | 2024-07-16 | no assertion criteria provided | clinical testing | The CC2D2A c.4084dupG variant is predicted to result in a frameshift and premature protein termination (p.Ala1362Glyfs*4). To our knowledge, this variant has not been reported in individuals with CC2D2A-related disorders in the literature. This variant is reported in 0.0065% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Loss-of-function variants in CC2D2A are expected to be pathogenic. This variant is interpreted as likely pathogenic. |